Insider · CIK 0001181175
Kenneth C Frazier
Files at EIKN (Eikon Therapeutics, Inc.). First filing Feb 6, 2026, latest Feb 6, 2026.
Kenneth C Frazier files SEC Form 4 as director at EIKN (Eikon Therapeutics, Inc.). Since Feb 6, 2026, Kenneth C Frazier has reported 1 open-market buy worth $2.0M and 0 open-market sells worth $0, the latest filed on Feb 6, 2026.
A track record needs three past buys with six months of prices behind them; Kenneth C Frazier has 0, so none is measured yet.
The newest scored trade: bought $2.0M of EIKN on Feb 4, 2026, filed Feb 6, 2026, scored 63 (notable). In the last 12 months: 1 buy worth $2.0M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EIKN: Eikon Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Eikon Therapeutics, Inc. | $2.0M 111,111 shares | - | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | EIKN Eikon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,873 | $0.00 | $0 | 25,873 | Mar 4, 2026 |
| Feb 4, 2026 | EIKN Eikon Therapeutics, Inc. | POpen-market purchase Common Stock | +111,111 | $18.00 | $2.0M | 111,111 | Feb 6, 2026 |
Questions about Kenneth C Frazier
Answered from the filings on this page, as of the latest one.
Is Kenneth C Frazier buying or selling?
In the last 12 months Kenneth C Frazier reported 1 open-market buy worth $2.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $2.0M of EIKN on Feb 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Kenneth C Frazier's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kenneth C Frazier has 0.
Where does Kenneth C Frazier file Form 4?
Kenneth C Frazier has filed Form 4 at EIKN (Eikon Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.